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Background:  Myxedema heart disease is a rare and potentially fatal disease entity. A high index of suspicion in cases of unexplained 
heart failure with early administration of thyroxine can be potentially lifesaving.
case:  A 58 year old woman was admitted with three days of worsening volume overload and marked lethargy. Her past medical history 
included hypertension and stage 2 chronic kidney disease. On physical examination the blood pressure was 68/40 mmHg, heart rate was 
69/min, there was jugular venous distension up to the angle of jaw, and moderate bilateral lower extremity edema with cool extremities. 
EKG showed low voltage in precordial and limb leads. Chest X- ray showed significant cardiomegaly. There was rapid clinical worsening 
with acute renal failure requiring continuous renal replacement therapy, acute respiratory failure requiring mechanical ventilation, and 
persistent hypotension requiring inotropic support with dobutamine and epinephrine. 
decision Making:  Echocardiogram showed LVEF 20%, severely reduced RV function, moderate mitral regurgitation, severe tricuspid 
regurgitation and moderate pericardial effusion without tamponade physiology. Due to the unexplained severe heart failure and concern 
for cardiogenic shock, we proceeded with right and left heart catheterization. The pulmonary capillary wedge pressure was 16 mmHg, right 
atrial pressure 20 mmHg , cardiac index 1.2 L/min/m2,and cardiac output 1.7 L/min. There were no ischemic foci. Her clinical course was 
complicated by episodes of bradycardia, hypothermia, hypoglycemia and hypotension. Thyroid panel showed TSH 29, Free T4 0.5 and free 
T3 0.6. She was given a loading dose of intravenous thyroxine followed by high maintenance dosing along with stress dose hydrocortisone. 
This was followed by improvement in hemodynamics and transient resolution of symptoms.
conclusion:  This case highlights the significance of timely diagnosis and prompt initiation of therapy in patients with unexplained 
acute heart failure, especially in the setting of confounding clinical scenarios. Early aggressive therapeutic institution is a possible key 
prerequisite to favorable clinical outcome.
